Ethacrynic Acid

Selected form

Etacrynic Acid

Treatment option: Ascites, Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Lymphedema, Nephrotic Syndrome, Edema, Pulmonary Edema, Heart Failure, Cirrhosis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ethacrynic Acid

Property	Description
Active ingredient	Etacrynic acid
Form	Oral Tablet, Intravenous Injection Solution
Pharmacological class	Loop Diuretic (High-Ceiling)
Common use	Reduction of Volume Overload and Edema
Origin	Synthetic (Non-Sulfonamide)

What Type of Diuretic is Ethacrynic Acid?

Ethacrynic Acid (INN: Etacrynic acid) is a highly potent, synthetic medication classified as a loop diuretic, also known as a high-ceiling diuretic. This drug belongs to the class of agents that act rapidly and powerfully on the kidney to promote the removal of fluids and salts from the body. Chemically, it is a derivative of phenoxyacetic acid and is critically noted as the only drug in its class that is a non-sulfonamide agent, a distinction that is clinically recognized as vital for patients with documented allergies or sensitivities to sulfonamide-containing diuretics.

What are the Available Forms and General Function?

This single-ingredient medication is supplied as an oral tablet for maintenance use and as an intravenous injection solution for situations where immediate fluid mobilization is required. The active component, Etacrynic acid, works by inhibiting the specific transport system in the kidney responsible for reabsorbing sodium and chloride, resulting in the retention of water in the renal tubules. This mechanism results in a powerful and rapid diuresis, demonstrating its effectiveness in significantly reducing circulating fluid volume.

What is the General Purpose of This Type of Medication?

The general purpose of Ethacrynic Acid is to achieve the rapid and substantial reduction of volume overload and associated tissue swelling, medically termed edema. A typical use scenario involves quickly clearing accumulated fluid to lessen the burden on the heart in cases of severe fluid retention. By facilitating the swift excretion of salt and water, this medication effectively lowers the total fluid volume in the circulation, which in turn alleviates strain on the cardiovascular system and supports the overall management of conditions characterized by excessive fluid retention.

Regulatory References

Ethacrynic Acid - StatPearls - NCBI Bookshelf

What side effects are possible with Ethacrynic Acid?

Possible side effects and safety information

Official regulatory documents classify the potential adverse reactions of Ethacrynic Acid primarily by frequency and the body system affected. As a potent diuretic, the most common adverse reactions are centered on Metabolism and Nutrition Disorders, specifically disturbances in fluid and electrolyte balance, such as hypokalemia (low potassium) and hyponatremia (low sodium).

Gastrointestinal Disorders are also frequently listed, including anorexia, nausea, and vomiting, with diarrhea sometimes being severe enough to require discontinuation of treatment. Reactions affecting the Ear and Labyrinth Disorders system are of particular note, including ototoxicity (hearing loss) and tinnitus. While this hearing loss is often temporary, cases of permanent deafness have been reported, primarily associated with high doses, rapid intravenous administration, or existing severe renal impairment.

Serious adverse reactions are classified as rare but are officially documented, impacting major organ systems. These include agranulocytosis (a severe decrease in white blood cells) under Blood and Lymphatic System Disorders, and severe liver injury like acute liver atrophy under Hepatobiliary Disorders.

Safety limitations explicitly contraindicate the use of Ethacrynic Acid in patients experiencing anuria (absence of urine production) and those in a state of hepatic coma or pre-coma. Safety considerations also note that older adults may be more susceptible to profound diuresis and resulting electrolyte imbalances. Furthermore, there is an established risk of enhanced ototoxicity when administered alongside other drugs known to cause hearing impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Ethacrynic Acid overdose results from excessive amounts of this potent drug, causing profound diuresis and severe water and electrolyte depletion, according to regulatory documents.

Documented Overdose Presentations

Manifestations: Officially documented signs of overdose include profound diuresis, excessive weight loss, confusion, acute hypotension, and clinical evidence of electrolyte imbalances, such as hyponatremia and hypokalemia.
Severe Outcomes: Excessive fluid loss carries the risk of circulatory collapse and the development of vascular thrombosis and embolism (including cerebral and pulmonary). The label also notes the risk of precipitating fatal arrhythmia and hepatic coma in susceptible patients.

Mandate for Emergency Action

Regulatory authorities explicitly require individuals to seek emergency medical attention immediately upon the manifestation of any overdose symptoms. If a person has collapsed, had a seizure, is having trouble breathing, or cannot be awakened, emergency services (911 or equivalent) must be contacted immediately.

Management and Considerations

No specific antidote is known for this condition. Management is defined as the immediate withdrawal of the drug and the administration of symptomatic and supportive treatment under careful medical supervision to restore fluid and electrolyte homeostasis.

Population-specific notes highlight that elderly cardiac patients and those with advanced cirrhosis are at increased risk for severe complications like thromboembolic events or hepatic failure following excessive diuresis.

Therapeutic Uses of Ethacrynic Acid

What Ethacrynic Acid Treats: Main Uses and Benefits

Ethacrynic acid is a potent medication belonging to the loop diuretic class. It is primarily utilized to manage conditions involving excessive fluid retention, helping to restore a proper fluid balance within the body.

Management of Edema

The primary therapeutic use of ethacrynic acid is the treatment of edema, which is the swelling caused by excess fluid trapped in the body's tissues. This condition often manifests in the feet, ankles, legs, or abdomen and is frequently associated with several underlying medical issues:

Congestive Heart Failure: In patients with heart failure, the heart may not pump blood efficiently, leading to fluid backup in the lungs and extremities. Ethacrynic acid assists in removing this excess fluid, which can help reduce the workload on the heart.
Renal Disease: When the kidneys are unable to filter waste and excess water effectively, fluid can accumulate. Ethacrynic acid is used to promote fluid excretion in individuals with various forms of kidney disease, including nephrotic syndrome.
Hepatic Cirrhosis: Advanced liver disease can lead to significant fluid buildup in the abdominal cavity (ascites). Ethacrynic acid may be used to manage this accumulation when other treatments are insufficient.

Specialized Therapeutic Applications

Beyond general edema management, ethacrynic acid serves specific roles in clinical settings, particularly for patients who may not respond to other types of diuretics:

Alternative for Sulfa-Allergic Patients: Unlike many other loop diuretics, ethacrynic acid does not contain a sulfonamide chemical structure. This makes it a critical therapeutic option for individuals who require potent diuresis but have a known allergy to sulfa drugs.
Short-term Management of Hospitalized Patients: It is sometimes used in acute settings for the short-term management of hospitalized pediatric and adult patients with significant fluid overload that has become resistant to more common therapies.

Benefits of Treatment

By facilitating the removal of excess water and salt (sodium and chloride) through the urine, ethacrynic acid provides several physiological benefits:

Reduction in Swelling: Effective diuresis leads to a visible and physical reduction in tissue swelling, which can improve mobility and comfort.
Improved Respiratory Function: In cases where fluid has accumulated in the lungs (pulmonary edema), the use of this medication can help clear the fluid, making it easier for the patient to breathe.
Fluid Balance Regulation: The medication helps the body maintain a more stable volume of extracellular fluid, preventing the complications associated with chronic fluid overload.

Regulatory References

MedlinePlus Drug Information, an NIH resource

Eligibility and Restrictions for Use

Ethacrynic acid is a loop diuretic primarily prescribed to treat edema (fluid retention) associated with conditions such as congestive heart failure, liver cirrhosis, and kidney disease. It is often an important treatment option for patients who have an allergy to sulfonamide-containing diuretics, as it lacks the sulfonamide chemical group.

Ethacrynic acid can be used in adults and has an established dosage for children aged 2 and older. Its use in infants under the age of 2 years is generally avoided unless deemed necessary by a healthcare provider, due to limited data.

Ethacrynic acid is contraindicated in several circumstances, including:

Condition	Reason for Concern
Anuria	Complete lack of urine production
History of severe watery diarrhea	May be a recurrent, severe side effect
Hypersensitivity	Known allergy to ethacrynic acid
Advanced cirrhosis	Use with extreme caution due to risk of severe electrolyte imbalance and hepatic encephalopathy
Concomitant ototoxic drugs	Increased risk of irreversible hearing loss (e.g., with aminoglycoside antibiotics)

Caution is also advised in patients with severe electrolyte imbalances (such as low potassium, sodium, or magnesium), severe renal impairment, or advanced liver disease, as the drug can worsen these conditions. Patients with diabetes or gout may also require closer monitoring, as ethacrynic acid can affect blood sugar and uric acid levels.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents for Ethacrynic Acid outline specific interactions classified by their potential to modify drug exposure or create pharmacodynamic risks. These restrictions and cautions are necessary to maintain therapeutic goals and avoid adverse outcomes.

Ethacrynic Acid co-administration with aminoglycoside and some cephalosporin antibiotics should be avoided because it may significantly increase the ototoxic potential of these agents, which occurs most frequently in patients with severe renal impairment. Likewise, Lithium generally should not be given concurrently, as Ethacrynic Acid reduces its renal clearance, creating a high risk of lithium toxicity.

Documented Interaction Outcomes

Co-administered Product Class	Official Interaction Description
Antihypertensive Agents	May increase hypotensive effects; dosage adjustments may be necessary.
NSAIDs (e.g., Indomethacin)	Can reduce the diuretic, natriuretic, and antihypertensive effects of Ethacrynic Acid.
Warfarin	Has been shown to displace from plasma protein, potentially requiring a reduction in anticoagulant dosage.
Corticosteroids	May increase the risk of gastric hemorrhage.

For patients with advanced cirrhosis receiving digitalis glycosides, the official label advises that the concurrent use of potassium chloride or a potassium-sparing agent may be advisable to mitigate or prevent hypokalemia.

Mechanism of Action

Targeting High-Capacity Renal Salt Transport

Ethacrynic acid acts as an inhibitor of the Na+/K+/2Cl- symporter (NKCC2), the primary ion transporter in the kidney's thick ascending limb. By blocking the reabsorption of sodium, chloride, and potassium, the drug initiates an osmotic cascade that retains large volumes of water within the renal tubule. This mechanism directly results in the reduction of extracellular fluid volume by causing a pronounced increase in the excretion of water and electrolytes.

Rapid Vascular Tone Modulation

The drug exerts a separate effect by causing vasodilation (widening) of both peripheral and renal blood vessels; this effect occurs quickly and is independent of the subsequent fluid loss. This extra-renal mechanism serves to immediately decrease the cardiac preload—the volume of blood returning to the heart—which reduces the hemodynamic load on the cardiovascular system.

Mechanism-Dependent Inner Ear Activity

Ethacrynic acid’s action extends to the NKCC1 transporter, a similar ion channel found in the inner ear’s stria vascularis. This off-target mechanism disrupts the precise electrolyte balance of the endolymph fluid, which is required for auditory and vestibular signaling. This disruption is the physiological consequence of the drug's action on the inner ear's ion transport.

Dosage and Administration Information

How to Use Ethacrynic Acid: Official Administration Guidelines

Ethacrynic Acid is administered through two official routes: the oral route using a 25 mg tablet, and the intravenous (IV) route using a 50 mg vial of Ethacrynate Sodium (a powder for injection). This dual approach dictates the standard administration protocol.

Dosage Regimens and Frequency

Oral dosing for adults typically begins at 50 mg once daily and is adjusted to a maintenance range of 50 mg to 200 mg daily. The maximum dose for severe, refractory cases is 400 mg daily (200 mg administered twice daily). The drug may be taken on a continuous daily schedule or an intermittent schedule, such as alternating days or cycles with planned rest periods. For children aged one year or older, the initial oral dose is 25 mg daily, with increases made in small, precise increments.

Administration and Preparation Specifics

Oral tablets are instructed to be taken after meals or with food to mitigate potential gastrointestinal irritation. The intravenous form requires specific preparation: the 50 mg powder must be reconstituted with 50 mL of Sodium Chloride Injection or 5% Dextrose Injection prior to administration. The resulting solution must be injected slowly over a period of several minutes, either directly into a vein or through the tubing of a running infusion. It is stated that the solution must not be administered intramuscularly or subcutaneously and should not be mixed with whole blood or its derivatives. For patients with cirrhosis and ascites, the initiation of therapy is often carried out in a hospital setting.

Recent Clinical Evidence

Research evidence / Overview of studies for Ethacrynic Acid

Evidence for Edema Associated with Chronic Organ Conditions

Ethacrynic Acid was studied for fluid retention, or edema, linked to conditions characterized by systemic or functional imbalance, such as Congestive Heart Failure, Cirrhosis of the Liver, and various Kidney Diseases. The foundational research utilized descriptive clinical trials to examine outcomes in adults, monitoring urine output (diuresis), body weight changes, and salt excretion patterns. Findings describe patterns related to measured fluid and salt excretion. The evidence is relevant in research contexts, including its use in patients whose fluid overload appeared unresponsive to other treatments in observational settings.

Evidence in Acute Fluid Overload and Specialized Use Cases

The drug was evaluated in research scenarios focusing on acute volume overload, often in intensive care settings. Research has also explored its role for patients who present with allergies or sensitivities to sulfonamide-based diuretics, as it is a chemically distinct agent. Comparative studies monitored short-term outcomes like negative fluid balance and fluid removal rates over a few days. The key limitation here is that higher-quality randomized controlled trials often focus on narrow populations (e.g., surgical settings), meaning results apply primarily to those specific groups.

Research in Specific Patient Groups

Research was studied for specific patient subgroups, including children (e.g., post-cardiac surgery) and older adults. These studies examined outcomes related to systemic or functional imbalance by monitoring short-term fluid balance and urine output. Research for certain groups remains insufficient, as the available data often derive from small sample sizes or highly specialized hospital settings, meaning the full range of evidence is limited.

Long-Term Studies and Durability of Response

Studies have explored the concept of durable effects by monitoring patient responses over defined time intervals in observational settings. However, the current evidence landscape contains limited information for long-term outcomes that go beyond basic maintenance of fluid balance. The focus of the foundational clinical investigation was primarily on the drug’s acute diuretic effect. Consequently, there is a lack of contemporary, long-duration studies examining outcomes such as sustained quality of life or long-term survival patterns.

The Landscape of Evidence: What Remains Unclear

Current research provides context but not individual predictions. Key limitations include the fact that studies focusing on systemic imbalance often measure surrogate endpoints (like fluid balance) rather than definitive, long-term clinical measures. Comparative evidence is lacking for a modern, large-scale comparison across broad patient groups. Finally, evidence quality varies across studies, with foundational evidence derived from historical data for core indications.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Ethacrynic Acid (FAQ)

Q: How quickly does Ethacrynic Acid start working after you take it?

A: According to official product information, Ethacrynic Acid is a fast-acting medication. The diuretic effect usually begins within 30 minutes after an oral dose is taken. If the medication is given intravenously (IV), the effect typically starts even faster, within about 5 minutes of the injection.

Q: What is the difference between Ethacrynic Acid and other common diuretics like Furosemide?

A: Ethacrynic Acid is chemically distinct from many other loop diuretics, such as furosemide. The key difference noted in the prescribing information is that Ethacrynic Acid is a non-sulfonamide agent. This distinction is often important for patients who have documented allergies or sensitivities to sulfa-containing drugs.

Q: Do you always have to take potassium supplements with Ethacrynic Acid?

A: Because Ethacrynic Acid is a potent diuretic, it can cause the body to lose essential electrolytes, including potassium. Therefore, supplementary potassium chloride may often be necessary during therapy. The need for a supplement is determined by a healthcare provider based on monitoring of serum electrolyte levels.

Q: What happens if you miss a dose of Ethacrynic Acid?

A: Official patient guidance suggests that if a dose is missed, it should be taken as soon as possible. However, if it is already close to the time for the next scheduled dose, the missed dose should be skipped entirely. The guidance is to then return to the regular dosing schedule and not to take two doses to make up for the missed one.

Q: Can Ethacrynic Acid cause dizziness or lightheadedness?

A: Yes, official labeling lists dizziness and lightheadedness as potential side effects. These sensations may also be related to changes like lower blood pressure or an imbalance of fluid and electrolytes, which are known effects of the drug.

Q: Is it okay to drink alcohol in moderation while taking Ethacrynic Acid?

A: It is important to be cautious because alcohol and Ethacrynic Acid may have an additive effect in lowering blood pressure. Consultation with a healthcare provider regarding alcohol consumption is generally recommended while taking this drug.

Q: Is it normal to feel tired when taking Ethacrynic Acid?

A: Regulatory documents indicate that fatigue and a general feeling of tiredness or weakness are listed as potential side effects of Ethacrynic Acid. If fatigue is severe or persistent, it is important to bring this to the attention of a healthcare provider.

Q: How often do people typically need follow-up appointments when starting Ethacrynic Acid?

A: Due to the drug's potent effects on the body's chemistry, the official product information advises close monitoring. Frequent lab tests, such as those for serum electrolytes, CO2, and BUN, should be performed early in therapy and periodically thereafter during active fluid removal. The need for this monitoring indicates that close medical follow-up is necessary.

Q: Does taking Ethacrynic Acid require a specific diet, like low sodium?

A: The drug is known to cause electrolyte loss, and this loss can be accentuated by rigid salt restriction. Patients who follow a low-salt or salt-free diet are advised to consult with their doctor. They may need to discuss adjustments to their diet or the potential need for potassium supplementation while on this medication.

Q: Can Ethacrynic Acid interact with common over-the-counter cold medications?

A: Official labeling specifically notes that certain non-steroidal anti-inflammatory drugs (NSAIDs), which are found in many over-the-counter cold remedies, can reduce the diuretic and blood-pressure-lowering effects of Ethacrynic Acid. Consultation with a healthcare provider is recommended before using any OTC products, particularly those that may affect blood pressure.

Q: What is the typical timeframe for seeing maximum fluid reduction with Ethacrynic Acid?

A: After an oral dose of Ethacrynic Acid is taken, the peak diuretic effect—the strongest fluid removal—occurs in about 2 hours. Overall, the effect of a single oral dose typically lasts for 6 to 8 hours.

Q: Can pregnant women safely use Ethacrynic Acid?

A: Official regulatory information indicates that there are no adequate and well-controlled studies of the drug's use in pregnant women. Therefore, the medication should only be used during pregnancy if clearly needed and the potential benefit is determined to justify any potential risk to the fetus.

Q: Is Ethacrynic Acid linked to any vitamin deficiencies?

A: While the medication's primary action is on major electrolytes, loop diuretics like Ethacrynic Acid have been documented to increase the urinary excretion of magnesium. This can potentially lead to hypomagnesemia (low magnesium levels). Magnesium is a mineral that plays a key role in several body functions.

Q: Why is it important to stay hydrated, even when taking a diuretic like Ethacrynic Acid?

A: This medication is a potent diuretic that can lead to profound diuresis, which is the excessive loss of water and electrolytes. Patients are instructed to follow their healthcare provider's recommendations regarding fluid intake. This is necessary to avoid becoming dehydrated and to maintain a proper balance of fluids and minerals in the body.

Q: Are there any specific lab tests needed before starting Ethacrynic Acid?

A: Yes, the product information advises that certain lab work is necessary before and during treatment. Specifically, frequent determinations of serum electrolytes, CO2, and BUN (blood urea nitrogen) should be performed. These tests are important to help monitor the effects of the medication and ensure that electrolyte levels remain stable.

Q: Can Ethacrynic Acid affect sleep patterns?

A: While the medication's effect on sleep is not a primary concern, the drug is known to cause increased urination. Patients are sometimes advised to consider the timing of their dose to help prevent frequent nighttime urination, which could potentially interfere with sleep.

Q: What are the signs that Ethacrynic Acid is working to reduce fluid?

A: A primary sign that the drug is working is an immediate increase in the amount of urine produced (diuresis). Healthcare providers also look for a visible reduction in excess fluid or edema, for instance, by monitoring body weight or measuring the girth of swollen limbs. Doctors monitor fluid output and patient weight as key metrics.

How should Ethacrynic Acid be stored and disposed of?

How to Store and Dispose of Ethacrynic Acid

Ethacrynic Acid tablets must be stored according to regulatory requirements to ensure product integrity.

Storage Requirements

The medicine requires storage at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), in a closed and well-closed container. The product must be shielded from heat, moisture, and direct light. It is prohibited to freeze the tablets, and temperature excursions must remain within 15 C to 30 C (59 F to 86 F). For safety, the medication must be kept out of the reach of children.

Disposal Instructions

Do not keep outdated medicine or product that is no longer needed. Official guidance states that users should ask a healthcare professional or local waste disposal service for instructions on how to properly discard unused Ethacrynic Acid tablets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

USA

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z